TWI571257B - Capsule preparation - Google Patents
Capsule preparation Download PDFInfo
- Publication number
- TWI571257B TWI571257B TW100106101A TW100106101A TWI571257B TW I571257 B TWI571257 B TW I571257B TW 100106101 A TW100106101 A TW 100106101A TW 100106101 A TW100106101 A TW 100106101A TW I571257 B TWI571257 B TW I571257B
- Authority
- TW
- Taiwan
- Prior art keywords
- capsule shell
- capsule
- pills
- danshen
- borneol
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本發明關於醫藥製劑技術領域,具體關於由不同顏色和材質的膠囊殼加工製成的藥品膠囊製劑。The invention relates to the technical field of medical preparations, in particular to a pharmaceutical capsule preparation prepared by processing a capsule shell of different colors and materials.
複方丹參滴丸是新一代的治療心血管疾病的藥物,由天津天士力製藥股份有限公司獨家生產。複方丹參滴丸以丹參為君藥、三七為臣藥、冰片為佐藥製成具有活血化瘀、宣痺止痛、芳香開竅之功效的藥物,臨床上主要用於治療心血管疾病。目前,國內市場的複方丹參滴丸是以180丸/瓶、150丸/瓶、100丸/瓶、60丸/瓶的規格包裝到高密度聚乙烯瓶中。服用時每次取出10丸服用。然而,這種服用方式在國外的接受度較低。為了進入國際市場,申請人計畫將複方丹參滴丸進一步製成膠囊製劑。Compound Danshen Dripping Pill is a new generation of medicine for treating cardiovascular diseases, which is exclusively produced by Tianjin Tianshili Pharmaceutical Co., Ltd. Compound Danshen Dripping Pills are made of Danshen as a drug, Sanqi as a drug, and borneol as an adjuvant. They are used to treat blood circulation, relieve phlegm, relieve pain and aroma. They are mainly used for the treatment of cardiovascular diseases. At present, the compound Danshen Dripping Pills in the domestic market are packaged in high-density polyethylene bottles in the specifications of 180 pills/bottle, 150 pills/bottle, 100 pills/bottle, and 60 pills/bottle. Take 10 pills each time you take it. However, this type of administration is less accepted abroad. In order to enter the international market, the applicant plans to further make the compound Danshen Dripping Pill into a capsule preparation.
作為藥品和食品的可食性包裝材料,不同性質的膠囊殼可能對藥品和食品的穩定性會產生一定的影響,目前,市場上銷售的硬膠囊殼一般分為明膠膠囊殼和植物膠囊殼兩種。As edible packaging materials for medicines and foods, capsule shells of different nature may have certain effects on the stability of medicines and foods. Currently, hard capsule shells sold on the market are generally divided into gelatin capsule shells and plant capsule shells. .
明膠膠囊殼是由來自動物的皮、骨、筋腱中的膠原質經部分水解後提純而獲得的蛋白質製品製成的,該膠囊殼內含有大量嘌呤。魚明膠膠囊殼就是近年來開發的新型態明膠膠囊殼。The gelatin capsule shell is made of a protein product obtained by partially hydrolyzing and purifying collagen from the skin, bone and tendons of an animal, and the capsule shell contains a large amount of strontium. Fish gelatin capsule shell is a new type of gelatin capsule shell developed in recent years.
植物膠囊殼是以由來源於植物的原料(原料含多聚糖和植物細胞壁的基本成分),例如,羥丙基甲基纖維素(HPMC)製成的膠囊殼。目前常見的植物膠囊殼有普魯蘭多糖製成的植物膠囊殼、海藻多糖製成的植物膠囊殼以及由羥丙基甲基纖維素製成的植物膠囊殼。The plant capsule shell is a capsule shell made of a plant-derived raw material (the raw material contains a polysaccharide and a basic component of a plant cell wall), for example, hydroxypropylmethylcellulose (HPMC). At present, the common plant capsule shells are a plant capsule shell made of pullulan, a plant capsule shell made of seaweed polysaccharide, and a plant capsule shell made of hydroxypropylmethylcellulose.
透明膠囊殼更容易增強中藥對顧客的親和性,提高感官認識,廣受國際市場歡迎。但不同顏色的透明膠囊殼由於反射了不同波長段的光線,導致藥物接受了不同波段能量的光線,因此不同顏色的透明膠囊殼對藥物本身的穩定性產生一定的影響。另外,不同材質的膠囊殼由於材質本身的吸濕性、穩定性、理化性質等差異,同樣導致對藥品穩定性的影響作用不同。The transparent capsule shell is more likely to enhance the affinity of Chinese medicine to customers and enhance sensory awareness, which is widely welcomed by the international market. However, the transparent capsule shells of different colors reflect the light of different wavelength bands, which causes the medicine to receive light of different wavelengths. Therefore, the transparent capsule shells of different colors have certain influence on the stability of the drug itself. In addition, capsule shells of different materials have different effects on the stability of the drug due to differences in hygroscopicity, stability, and physicochemical properties of the material itself.
為了使藥物得到最佳的保護作用,申請人經過長時間的研究,考察了不同材質和顏色的膠囊殼對藥品穩定性的影響作用,經過篩選較佳出有益於藥物穩定性的膠囊殼。In order to obtain the best protective effect of the drug, the applicant has studied the effect of capsule shells of different materials and colors on the stability of the drug after a long period of research, and the capsule shell which is beneficial to the stability of the drug is selected through screening.
本發明的目的在於提供一種穩定性好的複方丹參滴丸膠囊劑。The object of the present invention is to provide a compound Danshen dripping pill capsule with good stability.
本發明所述的膠囊製劑,由藥物和膠囊殼製成,藥物填裝於膠囊殼中,其中,該膠囊殼為有顏色的膠囊殼,該藥物為複方丹參滴丸。The capsule preparation of the present invention is prepared from a drug and a capsule shell, and the medicine is filled in a capsule shell, wherein the capsule shell is a colored capsule shell, and the medicine is a compound Danshen dripping pill.
該膠囊殼的顏色較佳為:橙色系-黃色系-綠色系-藍色系的膠囊殼,對應波長範圍是446nm-620nm。The color of the capsule shell is preferably an orange-yellow-green-blue capsule shell, and the corresponding wavelength range is 446 nm to 620 nm.
較佳的膠囊殼的顏色為:橙色系,對應波長範圍是592nm-620nm;藍色系,對應波長範圍是446nm-500nm;黃色系,對應波長範圍是577nm-592nm;和綠色系,對應波長範圍是500nm-577nm。The preferred color of the capsule shell is: orange, corresponding wavelength range is 592nm-620nm; blue, corresponding wavelength range is 446nm-500nm; yellow, corresponding wavelength range is 577nm-592nm; and green, corresponding wavelength range It is 500nm-577nm.
最佳的膠囊殼的顏色為黃色系,對應波長範圍是577nm-592nm;和綠色系,對應波長範圍是500nm-577nm。The color of the optimal capsule shell is yellow, the corresponding wavelength range is 577nm-592nm; and the green color, the corresponding wavelength range is 500nm-577nm.
該膠囊殼選自明膠膠囊殼和植物膠囊殼。The capsule shell is selected from the group consisting of a gelatin capsule shell and a plant capsule shell.
從材質角度考慮,該膠囊殼較佳為植物膠囊殼。From the material point of view, the capsule shell is preferably a plant capsule shell.
本發明的複方丹參滴丸由丹參、三七和冰片製備而成。The compound Danshen dripping pill of the invention is prepared from Danshen, Sanqi and borneol.
較佳地,相對於丹參、三七和冰片這三种中藥材的總重量,本發明的複方丹參滴丸由下述重量百分含量的原料藥製成:Preferably, the compound Danshen dropping pills of the present invention are made of the following weight percentages of the drug substance relative to the total weight of the three Chinese herbal medicines: salvia miltiorrhiza, notoginseng and borneol:
丹參 48.0%-97.0%Salvia miltiorrhiza 48.0%-97.0%
三七 1.0%-50.0%Sanqi 1.0%-50.0%
冰片 0.1%-3.0%。Borneol 0.1%-3.0%.
更佳地,相對於丹參、三七和冰片這三種中藥材的總重量,本發明的複方丹參滴丸由以下重量百分含量的原料藥製成:More preferably, the compound Danshen dropping pills of the present invention are made of the following weight percentages of the drug substance relative to the total weight of the three Chinese herbal medicines: salvia miltiorrhiza, notoginseng and borneol:
丹參 63.0%-94.0%Salvia 63.0%-94.0%
三七 4.0%-35.0%Sanqi 4.0%-35.0%
冰片 0.5%-2.0%。Borneol 0.5%-2.0%.
最佳地,相對於丹參、三七和冰片這三種中藥材的總重量,本發明的複方丹參滴丸由以下重量百分含量的原料藥製成:Most preferably, the compound Danshen dropping pills of the present invention are made of the following weight percentages of the drug substance relative to the total weight of the three Chinese herbal medicines: salvia miltiorrhiza, notoginseng and borneol:
丹參 82.87%Salvia 82.87%
三七 16.21%Sanqi 16.21%
冰片 0.92%。Borneol 0.92%.
本文中,原料藥是相對於輔料而言的,原料藥是製劑中的有效成分。本文中,原料藥是指未經進一步提純處理的生藥材或中藥飲片。該輔料是指在製劑的處方設計時,為解決製劑的成型性、有效性、穩定性、安全性加入處方中的、除原料藥以外的所有藥用物料的統稱。Herein, the drug substance is relative to the excipient, and the drug substance is an active ingredient in the preparation. In the present text, the raw material medicine refers to a raw medicine or a Chinese medicine decoction piece which has not been further purified. The auxiliary material refers to a general term for all the medicinal materials except for the raw material medicine, which are added to the prescription in order to solve the moldability, effectiveness, stability and safety of the preparation at the time of prescription design of the preparation.
在進行該配方前,該原料藥經過如下處理:The drug substance is processed as follows before the formulation is carried out:
該丹參是雙子葉植物唇形科(Labiatae)丹參Salvia miltiorrhiza Bge.的乾燥根及根莖。丹參可以切片或粉碎後使用。The Salvia miltiorrhiza is the dried root and rhizome of the dicotyledonous Labiatae salvia miltiorrhiza Bge. Salvia miltiorrhiza can be sliced or crushed for use.
該三七是指五加料植物三七Panax notoginseng(Bμrk.)F.H. Chen的乾燥根及根莖。The five feed means thirty-seven thirty-seven plant Panax notoginseng (Bμrk.) FH Chen dried roots and rhizomes.
該冰片是龍腦香科植物龍腦香的樹脂和揮發油加工品提取獲得的結晶,也可透過化學方法合成而獲得,使用前可以研細過篩以備用。The borneol is a crystal obtained by extracting the resin of the dipterocarp plant Dipterocarp and the volatile oil processed product, and can also be obtained by chemical synthesis, and can be finely sieved for use before use.
本發明的中藥組合物的製備可以採用現有技術的方法製備,例如,中國專利申請01136155.7、01820875.4、03144300.1、200310107279.5、200410018758.4、200410019827.3和02100884.1,以上專利申請文本在此併入本文作為參考。The preparation of the traditional Chinese medicine composition of the present invention can be carried out by a method of the prior art, for example, Chinese Patent Application No. 01136155.7, 01820875.4, 03144300.1, 200310107279.5, 200410018758.4, 200410019827.3 and 02100884.1, the disclosure of which is hereby incorporated by reference.
舉例來說,可以取丹參、三七藥材,沸水或鹼水煮提,過濾,合併濾液,並將濾液適當濃縮;在濃縮液中加入乙醇進行醇沉積,靜置,於上清液回收乙醇,濃縮成丹參三七浸膏;將所得浸膏與冰片及輔料混和均勻後,製成滴丸。For example, Danshen, Sanqi medicinal materials, boiling water or alkaline water can be taken, filtered, and the filtrate is combined, and the filtrate is appropriately concentrated; ethanol is added to the concentrated solution for alcohol deposition, and the ethanol is recovered in the supernatant. Concentrated into Danshen Sanqi extract; the obtained extract is mixed with borneol and auxiliary materials to form a dropping pill.
具體地說,複方丹參滴丸可以按照如下步驟製備:按以上比例稱取丹參、三七藥材,在水中或pH 7-9的水溶液中加熱回流提取2-4次,每次提取0.5-3小時,回流提取溫度為60-100℃,每次加水重量為藥材重量的2-12倍,使所得提取液過濾,濾液濃縮至相對密度為1.05-1.25,加乙醇至藥液的含醇量為50%-85%(v/v),靜置4-36小時,使上清液過濾,回收乙醇、收膏至糖度為50-90 brix的提取物(即,丹參三七浸膏);本發明的複方丹參滴丸所使用的基質輔料可以是聚乙二醇-6000,其凝固點係53-58℃,原料藥和輔料的重量之比是1:(0.31-0.49);將該所得浸膏與冰片及輔料混和均勻後,加熱熔融上述混合物(即,化料),移入滴丸機的滴罐,將熔融藥液滴至低溫冷卻液(例如,液體石蠟)中,除去冷卻液,選丸即可。化料溫度為60-100℃;冷卻液的溫度為0-10℃,較佳為5-10℃。Specifically, the compound Danshen dropping pills can be prepared according to the following steps: the Danshen and the Panax notoginseng are weighed according to the above ratio, and extracted by heating and refluxing in water or an aqueous solution of pH 7-9 for 2-4 times, each time extracting 0.5-3 hours. The reflux extraction temperature is 60-100 ° C, the weight of each added water is 2-12 times the weight of the medicinal material, the obtained extract is filtered, the filtrate is concentrated to a relative density of 1.05-1.25, and the alcohol is added to the liquid solution to have an alcohol content of 50. %-85%(v/v), standing for 4 to 36 hours, filtering the supernatant, recovering the ethanol, and collecting the extract to an extract having a sugar content of 50-90 brix (ie, Danshen Sanqi extract); the present invention The matrix adjuvant used in the compound Danshen dropping pills may be polyethylene glycol-6000, the freezing point of which is 53-58 ° C, and the weight ratio of the raw material drug to the auxiliary material is 1: (0.31 - 0.49); After the borneol and the auxiliary materials are uniformly mixed, the mixture (i.e., the chemical) is heated and melted, transferred to a drip tank of the dropping machine, and the molten medicine is dropped into a low-temperature cooling liquid (for example, liquid paraffin) to remove the cooling liquid, and the selected sample is can. The temperature of the chemical is 60-100 ° C; the temperature of the cooling liquid is 0-10 ° C, preferably 5-10 ° C.
另外,本發明的複方丹參滴丸含有輔料,該輔料可以僅為基質輔料,也可以是基質輔料和增塑性輔料二者的組合。其中,所使用的基質輔料也可以是植物來源的天然基質輔料,例如可以選自可藥用的D-核糖、果糖、木糖、海藻糖、棉子糖、麥芽糖、瓊脂糖、蔗糖酯、D-核糖酸-γ-內酯、赤蘚糖醇、山梨醇、木糖醇、阿拉伯醇、異麥芽醇、乳糖醇、蘋果酸、硬脂酸甘油酯、蟲膠、苯基乙二醇、聚氧乙烯烷基醚,以及含結晶水的上述化合物;該輔料還可以包括增塑性輔料,該增塑性輔料例如可以選自預膠化澱粉、羧甲基澱粉、阿拉伯膠、右旋糖酐、田菁膠、卡拉膠(角叉菜膠)、印度膠、紅藻膠、西黃蓍膠、羅望子膠、果膠、黃原膠、海藻酸及其鹽、瓊脂、乳糖、單硬脂酸甘油酯、聚氧乙烯單硬脂酸酯、交聯羧甲基纖維素鈉、二氧化矽等。Further, the compound Danshen dropping pill of the present invention contains an auxiliary material, which may be only a matrix auxiliary material, or a combination of a matrix auxiliary material and a plasticizing auxiliary material. Wherein, the matrix adjuvant used may also be a natural matrix adjuvant of plant origin, for example, may be selected from pharmaceutically acceptable D-ribose, fructose, xylose, trehalose, raffinose, maltose, agarose, sucrose ester, D - ribose-γ-lactone, erythritol, sorbitol, xylitol, arabinol, isomalt, lactitol, malic acid, glyceryl stearate, shellac, phenylethylene glycol, a polyoxyethylene alkyl ether, and the above compound containing crystal water; the auxiliary material may further comprise a plasticizing auxiliary material, which may be selected, for example, from pregelatinized starch, carboxymethyl starch, gum arabic, dextran, and phthalocyanine. Carrageenan (carrageenan), Indian gum, red algae gum, scutellaria gum, tamarind gum, pectin, xanthan gum, alginic acid and its salts, agar, lactose, glyceryl monostearate, Polyoxyethylene monostearate, croscarmellose sodium, cerium oxide, and the like.
該複方丹參滴丸可以是素丸,也可以是包衣丸。The compound Danshen dripping pill can be a vegetarian pill or a coated pill.
其中,所述複方丹參滴丸的素丸的具體製法例如可以為:Wherein, the specific preparation method of the compound pellet of the compound Danshen dropping pill can be, for example:
<成分>丹參、三七、冰片<ingredients> Danshen, Sanqi, borneol
<製法>取丹參三七浸膏,加入浸膏重量的2.5-3.5倍的聚乙二醇-6000,於85-90℃化料,化料均勻後,按處方量加入研細過篩後的冰片,攪拌混勻,轉移至滴丸機於80-85℃滴製即得。<Preparation method> Take Danshen Sanqi extract, add 2.5-3.5 times of the weight of the extract of polyethylene glycol-6000, and make the material at 85-90 °C. After the chemical is even, add the finely sieved according to the prescription amount. The borneol is stirred and mixed, and transferred to a dropping machine at 80-85 ° C to obtain a drop.
該複方丹參滴丸的包衣丸具體製法例如可以為:The specific preparation method of the coated pellet of the compound Danshen dripping pill can be, for example:
<成分>丹參、三七、冰片<ingredients> Danshen, Sanqi, borneol
<製法>取丹參三七浸膏,加入浸膏重量的2.5-3.5倍的聚乙二醇-6000,於85-90℃化料,化料均勻後,按處方量加入研細過篩後的冰片,攪拌混勻,轉移至滴丸機於80-85℃滴製,得到小滴丸的素丸。按照包衣增重6wt%的比例,用水溶解胃溶型包衣材料,充分攪拌均勻後,將素丸轉移到包衣設備內,在平均進風溫度85℃、平均片床溫度35-38℃、霧化壓力2bar、平均轉速15-23rpm、平均物料流速3-4g/min的條件下進行包衣即得。<Preparation method> Take Danshen Sanqi extract, add 2.5-3.5 times of the weight of the extract of polyethylene glycol-6000, and make the material at 85-90 °C. After the chemical is even, add the finely sieved according to the prescription amount. The borneol was stirred and mixed, and transferred to a dropping machine at 80-85 ° C to obtain a pellet of the pellet. According to the proportion of coating weight gain of 6wt%, dissolve the stomach-soluble coating material with water, stir well, transfer the pellets to the coating equipment, and the average inlet air temperature is 85 °C, the average bed temperature is 35-38 °C. The coating is obtained under the conditions of an atomization pressure of 2 bar, an average rotation speed of 15-23 rpm, and an average material flow rate of 3-4 g/min.
本發明的複方丹參滴丸膠囊產生了意想不到的效果,通過以下試驗進一步證明。The compound Danshen dripping pill capsule of the present invention produced an unexpected effect and was further confirmed by the following experiment.
實驗用膠囊殼購買自中美合資蘇州膠囊有限公司,是美國輝瑞公司膠囊部(CAPSMGEL)的生產基地之一。The experimental capsule shell was purchased from Sino-US joint venture Suzhou Capsule Co., Ltd. and is one of the production bases of Pfizer Capsule (CAPSMGEL).
選擇不同顏色和材質的膠囊殼內裝複方丹參滴丸,作為試驗樣品,在強光照射和加速試驗的環境下利用HPLC、MV、GC的手段檢測丹參、三七、冰片各指標成分含量的變化。The capsules of different colors and materials were selected to be filled with compound Danshen dropping pills as test samples. The contents of various components of Danshen, Sanqi and Borneol were detected by HPLC, MV and GC in the environment of intense light irradiation and accelerated test. .
穩定性試驗考察箱(MMM)CLIMACELL 404,附帶光照功能。Stability Test Case (MMM) CLIMACELL 404 with lighting function.
高效液相色譜儀Agilent 1100High Performance Liquid Chromatograph Agilent 1100
紫外可見光譜儀Hitachi M3010UV-visible spectrometer Hitachi M3010
氣相色譜儀Agilent 8890Gas chromatograph Agilent 8890
根據試驗目的和技術可行性,選取複方丹參小滴丸為試驗樣品,利用天津天士力製藥股份有限公司生產線進行滴製,試驗樣品分為包衣丸和素丸2種。小滴丸的平均丸重10mg,普通1號膠囊可以裝進30-35粒。According to the purpose of the test and the technical feasibility, the compound Danshen Xiao Drop Pills was selected as the test sample, and the production line of Tianjin Tianshili Pharmaceutical Co., Ltd. was used for dripping. The test samples were divided into two types: coated pill and vegetarian pill. The average pill weight of the small drop pill is 10 mg, and the ordinary No. 1 capsule can be filled with 30-35 tablets.
複方丹參滴丸的滴製工藝:The dropping process of compound Danshen dripping pills:
(1) 小滴丸素丸(1) Droplet Pills
丹參41.06g 三七8.03g 冰片0.46gSalvia 41.06g Sanqi 8.03g borneol 0.46g
輔料聚乙二醇-6000 18gExcipients Polyethylene Glycol-6000 18g
製成1000粒滴丸Made of 1000 pills
取經粗粉碎的丹參、三七藥材至提取罐中,加入該丹參和三七藥材的5倍量的水,煎煮2小時,過濾,濾渣進行第二次提取,加入該丹參和三七藥材的4倍量的水,煎煮1小時,過濾,濾渣棄去,合併濾液。濾液減壓濃縮至相對密度為1.05,緩慢加入95%(v/v)的乙醇,使藥液含醇濃度為69-71%(v/v),靜置12小時。取醇沉積後藥液的上清液進行過濾,濾液回收乙醇,收膏至糖度為50 brix的提取物(即,丹參三七浸膏)。Take the coarsely pulverized Salvia miltiorrhiza Bge. and Radix Notoginseng herbs into the extraction tank, add 5 times the amount of water of the Salvia miltiorrhiza and Radix Notoginseng, boil for 2 hours, filter, filter the residue for the second extraction, add the Danshen and Sanqi herbs. 4 times the amount of water, decocted for 1 hour, filtered, the filter residue was discarded, and the filtrate was combined. The filtrate was concentrated under reduced pressure to a relative density of 1.05, and 95% (v/v) of ethanol was slowly added thereto to make the drug solution having an alcohol concentration of 69-71% (v/v) and allowed to stand for 12 hours. The supernatant of the drug solution after alcohol deposition was filtered, and the filtrate was recovered to ethanol, and the extract was collected to an extract having a sugar content of 50 brix (ie, Salvia miltiorrhiza extract).
取丹參三七浸膏,加入浸膏重量的2.5-3.5倍的聚乙二醇-6000,於85-90℃化料,化料均勻後,按處方量加入研細過篩後的冰片,攪拌混勻,轉移至滴丸機於80-85℃滴製即得。Take Danshen Sanqi extract, add 2.5-3.5 times of the weight of the extract of polyethylene glycol-6000, at 85-90 °C, after the chemical is even, add the finely sifted borneol according to the prescription, stir Mix and transfer to a dropping machine at 80-85 ° C to obtain.
<規格>平均丸重10mg/丸。<Specification> The average pill weight is 10 mg/pill.
(2) 小滴丸包衣丸(2) Small drop pill coated pills
丹參41.06g 三七8.03g 冰片0.46gSalvia 41.06g Sanqi 8.03g borneol 0.46g
輔料聚乙二醇-6000 18gExcipients Polyethylene Glycol-6000 18g
製成1000粒滴丸Made of 1000 pills
取經粗粉碎的丹參、三七藥材至提取罐中,加入該丹參和三七藥材的5倍量pH為9的NaOH水溶液,煎煮2小時,過濾,濾渣進行第二次提取,加入該丹參和三七藥材的4倍量的上述鹼溶液,煎煮1小時,過濾,濾渣棄去,合併濾液。將濾液減壓濃縮至相對密度為1.25,緩慢加入95%(v/v)的乙醇,使藥液含醇濃度在69-71%(v/v),靜置12小時。取醇沉積後藥液的上清液進行過濾,濾液回收乙醇,收膏至糖度為90 brix的提取物(即,丹參三七浸膏)。The crude smashed Danshen and Sanqi medicinal materials were taken into the extraction tank, and 5 times of the NaOH aqueous solution of the Salvia miltiorrhiza and the Panax notoginseng was added, and the NaOH solution was decocted for 2 hours, filtered, and the filter residue was extracted for the second time. Four times the amount of the above alkaline solution of the medicinal material of Panax notoginseng, decocted for 1 hour, filtered, and the filter residue was discarded, and the filtrate was combined. The filtrate was concentrated under reduced pressure to a relative density of 1.25, and 95% (v/v) of ethanol was slowly added to make the drug solution having an alcohol concentration of 69-71% (v/v) and allowed to stand for 12 hours. The supernatant of the drug solution after alcohol deposition was filtered, and the filtrate was recovered to ethanol, and the extract was collected to an extract having a sugar content of 90 brix (ie, Salvia miltiorrhiza extract).
取丹參三七浸膏,加入浸膏重量的2.5-3.5倍的聚乙二醇-6000,於85-90℃化料,化料均勻後,按處方量加入研細過篩後的冰片,攪拌混勻,轉移至滴丸機於80-85℃滴製而得到小滴丸素丸。Take Danshen Sanqi extract, add 2.5-3.5 times of the weight of the extract of polyethylene glycol-6000, at 85-90 °C, after the chemical is even, add the finely sifted borneol according to the prescription, stir Mix and transfer to a dropping machine at 80-85 ° C to obtain a small drop pill.
按照包衣增重6wt%的比例用水溶解胃溶型包衣材料,充分攪拌均勻後,將素丸轉移到包衣設備內,在平均進風溫度85℃、平均片床溫度35-38℃、霧化壓力2bar、平均轉速15-23rpm、平均物料流速3-4g/min的條件下進行包衣,即得小滴丸包衣丸。Dissolving the stomach-soluble coating material in water at a ratio of 6 wt% of the weight gain of the coating, fully stirring, and transferring the pill into the coating device at an average inlet air temperature of 85 ° C, an average bed temperature of 35-38 ° C, The coating was carried out under the conditions of an atomization pressure of 2 bar, an average rotation speed of 15-23 rpm, and an average material flow rate of 3-4 g/min, that is, a small drop pill coated pellet.
<規格>平均丸重11mg/丸。<Specification> The average pill weight is 11 mg/pill.
選用明膠和植物兩種材質的膠囊殼,覆蓋全可見光波段的紅、橙、黃、綠、青、藍、紫各顏色共16種膠囊殼(表1)。Capsule shells of gelatin and plant are used to cover 16 kinds of capsule shells of red, orange, yellow, green, cyan, blue and purple in the visible light range (Table 1).
選具有代表性的17種滴丸和膠囊殼的不同組合進行試驗,在不同材質和顏色的膠囊殼內填裝有素丸或包衣丸(表2)。Different combinations of 17 kinds of drop pills and capsule shells were selected for testing, and capsules or coated pellets were filled in capsule shells of different materials and colors (Table 2).
試驗分為2大部分,強光照射試驗和加速穩定性考察試驗。The test is divided into two parts, the strong light irradiation test and the accelerated stability test.
強光照射條件:溫度為25℃,相對濕度為60%,風速為100%。設定40%光照,距離10釐米。照射強度達到4500 Lμx。在第0天、5天、10天取樣。Strong light irradiation conditions: temperature is 25 ° C, relative humidity is 60%, and wind speed is 100%. Set 40% light, 10 cm distance. The irradiation intensity reached 4500 Lμx. Samples were taken on days 0, 5, and 10.
先選擇MWB和MWS兩個樣品進行,考察光照是否會對複方丹參滴丸產生影響;再選擇MBBB、MBZBB、MCB、MZB、MHB、MHMB、MLB、MGB、MBHB不同顏色、同一材質的明膠膠囊殼內裝包衣丸的9種樣品進行,考察在強光照射下不同顏色的膠囊殼對複方丹參滴丸的保護作用的優劣。First select two samples of MWB and MWS to investigate whether the light will affect the compound Danshen dropping pills; then select the gelatin capsule shells of different colors and the same material of MBBB, MBZBB, MCB, MZB, MHB, MHMB, MLB, MGB, MBHB. Nine samples of coated pellets were taken to investigate the protective effects of capsule shells of different colors under the irradiation of strong light on compound Danshen dropping pills.
加速試驗條件:溫度為40℃,相對濕度75%。在第0月、1月、2月、3月、4.5月、6月取樣。Accelerated test conditions: temperature 40 ° C, relative humidity 75%. Samples were taken in the months of January, January, February, March, April, and June.
選擇上述17種不同顏色和材質的膠囊殼內裝複方丹參滴丸的素丸和包衣丸進行,考察在加速試驗全過程中複方丹參滴丸的變化程度。The capsules and coated pellets of the compound Danshen dripping pills were prepared in the capsule shells of the above 17 different colors and materials, and the degree of change of the compound Danshen dripping pills in the whole process of the accelerated test was investigated.
測定以下成分的含量:丹參中的指標成分:丹參素、原兒茶醛、丹酚酸L、丹酚酸M、丹酚酸D、迷迭香酸、丹酚酸B和丹酚酸A;三七中的指標成分:R1、Rg1+Re、Rb1、Rc、Rb2、Rb3和Rd;總酚酸、總皂苷和總糖;以及冰片。Determination of the content of the following components: Danshen in the indicator components: Danshensu, protocatechuic aldehyde, salvianolic acid L, salvianolic acid M, salvianolic acid D, rosmarinic acid, salvianolic acid B and salvianolic acid A; Indicator components in Panax notoginseng: R1, Rg1+Re, Rb1, Rc, Rb2, Rb3 and Rd; total phenolic acid, total saponin and total sugar; and borneol.
外觀變化,考察經過極限條件下,滴丸的外觀變化。是否出現乾裂或是濕黏、是否結塊、表面是否出現白色析出物、顏色和丸重是否發生變化。The appearance changes, and the appearance changes of the dropping pills under the limit conditions are examined. Whether it is dry or wet, whether it is agglomerated, whether white precipitates appear on the surface, whether the color and the weight of the pellet change.
3.3.1.1供試品製備3.3.1.1 Preparation of test materials
取各樣品中的複方丹參滴丸10粒於10ml容量瓶中,加入適量蒸餾水,超音波15min,定容至刻度,離心過濾。以上樣品同時製備2份。各樣品的進樣量均為10μl。Take 10 samples of compound Danshen dropping pills in each sample in a 10 ml volumetric flask, add appropriate amount of distilled water, supersonic for 15 min, dilute to volume, and centrifuge. The above samples were prepared in two portions at the same time. The injection volume of each sample was 10 μl.
取丹參素、原兒茶醛、迷迭香酸、丹酚酸B、丹酚酸A、丹酚酸L、丹酚酸M、丹酚酸D標準品製備標準品溶液,各樣品的進樣量均為10μl。Take Danshensu, protocatechuic aldehyde, rosmarinic acid, salvianolic acid B, salvianolic acid A, salvianolic acid L, salvianolic acid M, salvianolic acid D standard preparation standard solution, injection of each sample The amount is 10 μl.
3.3.1.2 HPLC方法3.3.1.2 HPLC method
Agilent SB-C18分析柱(4.6mm×250mm)Agilent SB-C18 analytical column (4.6mm × 250mm)
流動相:A相:0.02%(v/v)磷酸水溶液;B相:含0.02%(v/v)磷酸的80%乙腈水溶液Mobile phase: Phase A: 0.02% (v/v) aqueous phosphoric acid; Phase B: 80% acetonitrile in water containing 0.02% (v/v) phosphoric acid
線性梯度洗脫程式:0min(90:10)、8min(78:22)、15min(74:26)、35min(61:39)Linear gradient elution program: 0min (90:10), 8min (78:22), 15min (74:26), 35min (61:39)
流速1ml/min,檢測波長280nm,柱溫30℃。The flow rate was 1 ml/min, the detection wavelength was 280 nm, and the column temperature was 30 °C.
丹參中各指標成分的保留時間為:丹參素5.842min、原兒茶醛9.750min、丹酚酸L為17.106min、丹酚酸M為18.041min、丹酚酸D為20.588min、迷迭香酸24.005min、丹酚酸B為27.908min、丹酚酸A為31.085min。The retention time of each indicator component in Salvia miltiorrhiza Bunge was: 5.842min of Danshensu, 9.750min of protocatechuic aldehyde, 17.106min of salvianolic acid L, 18.041min of salvianolic acid M, 20.588min of salvianolic acid D, rosmarinic acid 24.005 min, salvianolic acid B was 27.908 min, and salvianolic acid A was 31.085 min.
3.3.2.1供試品製備3.3.2.1 Preparation of test materials
取各樣品1g,溶於10ml 4%(v/v)氨水,超音波使全部溶解,過0.45μm濾膜,取5ml濾液過C18小柱,10ml水洗後用甲醇洗脫,定容到10ml容量瓶中。以上樣品同時製備2份。各樣品的進樣量均為20μl。Take 1g of each sample, dissolve it in 10ml of 4% (v/v) ammonia water, dissolve all the ultrasonic waves, pass 0.45μm filter, take 5ml filtrate through C18 column, wash with 10ml water, elute with methanol, make up to 10ml capacity In the bottle. The above samples were prepared in two portions at the same time. The injection volume of each sample was 20 μl.
取R1、Rg1+Re、Rb1、Rc、Rb2、Rb3、Rd標準品製備標準品溶液,各樣品的進樣量均為20μl。A standard solution was prepared from the standards of R1, Rg1+Re, Rb1, Rc, Rb2, Rb3, and Rd, and the injection amount of each sample was 20 μl.
3.3.2.2 HPLC方法3.3.2.2 HPLC method
Agilent SB-C18分析柱(4.6mm×250mm)Agilent SB-C18 analytical column (4.6mm × 250mm)
流動相:A相:0.01%(v/v)醋酸水溶液;B相:含0.01%(v/v)醋酸的乙腈水溶液。Mobile phase: Phase A: 0.01% (v/v) aqueous acetic acid; Phase B: aqueous acetonitrile solution containing 0.01% (v/v) acetic acid.
流速0.8ml/min,檢測波長203nm,柱溫30℃。The flow rate was 0.8 ml/min, the detection wavelength was 203 nm, and the column temperature was 30 °C.
三七中各指標成分的保留時間為:R1為11.001min、Rg1+Re為12.252min、Rb1為20.142min、Rc為20.877min、Rb2為22.418min、Rb3為23.422min、Rd為25.151min。The retention time of each indicator component in Panax notoginseng was: R1 was 11.001min, Rg1+Re was 12.252min, Rb1 was 20.142min, Rc was 20.877min, Rb2 was 22.418min, Rb3 was 23.422min, and Rd was 25.151min.
3.3.3.1總酚酸含量3.3.3.1 Total phenolic acid content
原兒茶醛溶液為對照品溶液,在對照品溶液、樣品溶液及空白對照溶液加入0.3wt%十二烷基磺酸鈉及0.6wt%鐵氰化鉀溶液、0.9wt%三氯化鐵溶液,利用顯色反應,按對照品比較法計算樣品中總酚酸含量。The protocatechuic aldehyde solution is a reference solution, and 0.3 wt% sodium dodecyl sulfate and 0.6 wt% potassium ferricyanide solution and 0.9 wt% ferric chloride solution are added to the reference solution, the sample solution and the blank control solution. Using the color reaction, the total phenolic acid content in the sample was calculated according to the comparison method of the reference substance.
3.3.3.2總皂苷含量3.3.3.2 Total saponin content
人參皂苷Rg1溶液為對照品溶液,加入5wt%香草醛-冰醋酸溶液和高氯酸,發生顯色反應,以不同濃度的標準品溶液的吸光度繪製標準曲線,計算樣品中總皂苷的含量。The ginsenoside Rg1 solution was used as a reference solution, and a coloring reaction was carried out by adding 5 wt% vanillin-glacial acetic acid solution and perchloric acid, and a standard curve was prepared by taking the absorbance of the standard solution of different concentrations to calculate the total saponin content in the sample.
3.3.3.3總糖含量3.3.3.3 Total sugar content
以葡萄糖為對照品溶液,加入蒽酮試劑,發生顯色反應,以不同濃度的標準品溶液的吸光度繪製標準曲線,計算樣品中總糖的含量。Glucose was used as the reference solution, and the fluorenone reagent was added to develop a color reaction. The standard curve was prepared by the absorbance of the standard solution of different concentrations, and the total sugar content in the sample was calculated.
3.3.4.1供試品製備3.3.4.1 Preparation of test articles
以萘標準物為內標溶液,以冰片和異冰片標準品製成標準品溶液,進樣量為1μl。The naphthalene standard was used as the internal standard solution, and the standard solution was prepared from the borneol and isobornyl standards, and the injection amount was 1 μl.
稱取壓破包衣的滴丸0.5g,於50ml塑膠離心管中,加水10ml,加乙酸乙酯25ml劇烈震搖萃取,用吸管吸取萃取液置於50ml容量瓶中。依此法再用乙酸乙酯萃取兩次,每次萃取使用的乙酸乙酯的量為10ml,合併萃取液,加內標液4ml,最後用乙酸乙酯定容至刻度,搖勻作為供試品溶液。進樣量為1μl。Weigh 0.5 g of the crushed coated pellets, add 10 ml of water in a 50 ml plastic centrifuge tube, add 25 ml of ethyl acetate to shake vigorously, and extract the extract with a pipette into a 50 ml volumetric flask. In this way, it was extracted twice with ethyl acetate, and the amount of ethyl acetate used in each extraction was 10 ml. The extracts were combined, 4 ml of internal standard solution was added, and finally, the volume was adjusted to the mark with ethyl acetate, and shaken to serve as a test. Product solution. The injection volume was 1 μl.
3.3.4.2色譜條件3.3.4.2 Chromatographic conditions
HP5% PHME siloxana 30m(柱長)×0.25mm(膜厚)石英毛細管柱;柱溫:自60℃起,以15℃/min的速度升溫至135(150)℃,維持2min,總過程8min;FID(氫火焰離子化檢測器);240℃;載氣:氮氣;流速:2.6ml/min;氣化室溫度200℃;理論塔板數按萘計算應不低於10000,分離度大於2。HP5% PHME siloxana 30m (column length) × 0.25mm (film thickness) quartz capillary column; column temperature: from 60 ° C, the temperature is raised to 135 (150) ° C at 15 ° C / min, maintained for 2 min, the total process 8 min; FID (hydrogen flame ionization detector); 240 ° C; carrier gas: nitrogen; flow rate: 2.6 ml / min; gasification chamber temperature 200 ° C; theoretical plate number according to naphthalene should not be less than 10,000, the degree of separation is greater than 2.
雙尾成對t檢驗(軟體為:SPSS13.0)進行t檢驗,以確定各指標在實驗條件下是否有顯著性變化。Two-tailed paired t-test (software: SPSS 13.0) was subjected to t-test to determine whether the indicators had significant changes under the experimental conditions.
利用效率評價模型對包裝的優劣進行評價。處理過程中使用的方法是資料包絡分析法(DEA),具體模型是超效率模型,以不同包裝為考察物件,以各不同包裝的初始指標為輸入物件,以不同指標各月份的測量值為輸出物件,經MYDEA軟體進行計算後得到各包裝不同月份的成分保留效率。成分損失越少,則效率值越高,反之亦然。The efficiency evaluation model is used to evaluate the advantages and disadvantages of the packaging. The method used in the process is Data Envelopment Analysis (DEA). The specific model is a super-efficiency model. The different packages are used to examine the objects. The initial indicators of different packages are input objects, and the measured values of different indicators are output. The object is calculated by the MYDEA software to obtain the component retention efficiency of each package in different months. The less the component loss, the higher the efficiency value and vice versa.
9種顏色的膠囊殼樣品按照0、5、10天分別取樣進行19種指標成分的檢驗(見表3-6)。所述的19種指標成分分別為丹參部分的8種指標成分(表3),三七部分的7種指標成分(表4),3種大類成分(總酚酸、總皂苷以及總糖)(表5);以及冰片(表6)。Samples of the capsules of 9 colors were sampled at 0, 5, and 10 days for inspection of 19 indicator components (see Table 3-6). The 19 indicator components are the eight indicator components of the Salvia miltiorrhiza (Table 3), the seven indicator components of the Panax notoginseng (Table 4), and the three major components (total phenolic acid, total saponin, and total sugar). Table 5); and borneol (Table 6).
17種不同材質和顏色的膠囊殼樣品按照0、1、2、3、4.5、6個月分別取樣,進行上述19種指標成分的檢驗(見表7-10)以及外觀變化的判斷(見表11)。Samples of capsule shells of 17 different materials and colors were sampled at 0, 1, 2, 3, 4.5, and 6 months, and the above 19 indicators were tested (see Table 7-10) and the judgment of appearance changes (see table). 11).
4.3.1強光照射實驗資料的統計分析結果(見表12)4.3.1 Statistical analysis results of experimental data of strong light irradiation (see Table 12)
4.3.2加速穩定性試驗資料的統計分析結果(見表13)4.3.2 Statistical analysis results of accelerated stability test data (see Table 13)
4.3.3加速穩定性實驗剔除非顯著性變化指標後的評價結果與所有指標評價結果兩種的t檢驗結果(見表14)4.3.3 Accelerated stability test The t-test results of the evaluation results after the significant change index and the evaluation results of all the indicators (see Table 14)
4.3.4 17種膠囊殼的最終評價結果(見表15)4.3.4 Final evaluation results of 17 capsule shells (see Table 15)
通過加速試驗的結果看出,對膠囊殼內的內容物保護作用,無論是從滴丸外觀和成分含量變化來看,相對於明膠膠囊殼,更佳的是植物膠囊殼。As a result of the accelerated test, it is seen that the protective effect on the contents of the capsule shell, whether from the appearance of the dropping pills and the content of the components, is more preferably the capsule shell of the capsule than the shell of the gelatin capsule.
由強光照射試驗資料的統計結果(表12)看,強光對複方丹參滴丸中各成分是有影響的,不同顏色的膠囊殼保護能力各不相同,但是,只要是有顏色的膠囊殼就會對內容物盡到保護作用,而不透明白色無論在顯著指標還是全部指標的評分中,都排在末位。實驗資料還能夠對不同顏色膠囊殼進行排序。總體而言,較佳的顏色為:橙色系-黃色系-綠色系-藍色系的膠囊殼,對應波長範圍是446nm-620nm。具體而言,橙色系,對應波長範圍是(592nm-620nm);藍色系,對應波長範圍是(446nm-500nm);黃色系,對應波長範圍是577nm-592nm和綠色系,對應波長範圍是500nm-577nm。其中,能散射出中波長可見光(500-592nm),即黃色系(對應波長範圍是577nm-592nm)和綠色系(對應波長範圍是500nm-577nm)的膠囊殼,對複方丹參滴丸的保護作用最強。According to the statistical results of the strong light irradiation test data (Table 12), the glare has an effect on the components of the compound Danshen dropping pills, and the protective ability of the capsule shells of different colors is different, but as long as it is a colored capsule shell The content will be protected, and the opaque white will be ranked last in both the significant indicator and the score of all indicators. The experimental data can also sort the capsule shells of different colors. In general, the preferred color is an orange-yellow-green-blue capsule shell having a corresponding wavelength range of 446 nm to 620 nm. Specifically, the orange system has a corresponding wavelength range of (592 nm to 620 nm); the blue system has a corresponding wavelength range of (446 nm to 500 nm); the yellow system has a corresponding wavelength range of 577 nm to 592 nm and a green color, and the corresponding wavelength range is 500 nm. -577nm. Among them, it can scatter the medium-wavelength visible light (500-592nm), that is, the yellow (corresponding wavelength range is 577nm-592nm) and the green (corresponding wavelength range is 500nm-577nm) capsule shell, which protects the compound Danshen dripping pills. The strongest.
根據加速穩定性實驗的最終統計結果(表15),能夠得出如下結論:Based on the final statistical results of the accelerated stability experiment (Table 15), the following conclusions can be drawn:
(1)對於膠囊的材質,植物膠囊殼優於明膠膠囊殼;(2)對於膠囊的顏色,較佳為橙色系-黃色系-綠色系-藍色系的膠囊殼,對應波長範圍是446nm-620nm;更佳為黃色系(對應波長範圍是577nm-592nm)和綠色系(對應波長範圍是500nm-577nm)的膠囊殼;(3)綜合上述兩方面的考慮,對於複方丹參滴丸膠囊較佳的膠囊殼種類有:植物黃色膠囊殼、植物綠色膠囊殼、明膠黃色膠囊殼和明膠綠色膠囊殼。另外,對於膠囊殼的顏色,可以適當放寬波長範圍至橙色和藍色。(1) For the material of the capsule, the plant capsule shell is superior to the gelatin capsule shell; (2) For the color of the capsule, an orange-yellow-green-blue capsule shell is preferred, and the corresponding wavelength range is 446 nm- 620 nm; more preferably a yellow shell (corresponding to a wavelength range of 577 nm to 592 nm) and a green shell (corresponding to a wavelength range of 500 nm to 577 nm); (3) combining the above two considerations, preferably for the compound Danshen dripping pill capsule The capsule shells are: plant yellow capsule shell, plant green capsule shell, gelatin yellow capsule shell and gelatin green capsule shell. In addition, for the color of the capsule shell, the wavelength range can be appropriately relaxed to orange and blue.
綜上所述,本發明的複方丹參滴丸膠囊,有益於維持複方丹參滴丸的理化性質和活性成分的穩定性。In summary, the compound Danshen dripping pill capsule of the present invention is beneficial for maintaining the physical and chemical properties of the compound Danshen dripping pills and the stability of the active ingredients.
通過以下具體實施方式進一步說明本發明。The invention is further illustrated by the following detailed description.
丹參41.06g 三七8.03g 冰片0.46gSalvia 41.06g Sanqi 8.03g borneol 0.46g
輔料聚乙二醇-6000 18gExcipients Polyethylene Glycol-6000 18g
製成1000粒滴丸Made of 1000 pills
取經粗粉碎的丹參、三七藥材至提取罐中,加入上述丹參和三七藥材的5倍量水,煎煮2小時進行過濾,濾渣進行第二次提取,加入該丹參和三七藥材的4倍量水,煎煮1小時,過濾,濾渣棄去,合併濾液。濾液減壓濃縮至相對密度為1.05,緩慢加入95%(v/v)的乙醇,使藥液含醇濃度在69-71%(v/v),靜置12小時。取醇沉後藥液的上清液,過濾,濾液回收乙醇,收膏至糖度為50 brix的提取物。Take the coarsely pulverized Salvia miltiorrhiza and Radix Notoginseng herbs into the extraction tank, add 5 times the amount of water of the above-mentioned Danshen and Sanqi medicinal materials, decoct for 2 hours for filtration, filter residue for the second extraction, and add the Danshen and Sanqi medicinal materials. Double the amount of water, decoct for 1 hour, filter, discard the filter residue, and combine the filtrate. The filtrate was concentrated under reduced pressure to a relative density of 1.05, and 95% (v/v) of ethanol was slowly added to make the drug solution having an alcohol concentration of 69-71% (v/v) and allowed to stand for 12 hours. The supernatant of the alcohol solution was taken, filtered, and the filtrate was recovered to ethanol, and the extract was collected to an extract having a sugar content of 50 brix.
取丹參三七浸膏,加入浸膏重量的2.5-3.5倍的聚乙二醇-6000,於85-90℃化料,化料均勻後,按處方量加入研細過篩後的冰片,攪拌混勻,轉移至滴丸機於80-85℃滴製得到素丸,最後,將得到的素丸包裹上586nm黃色的植物膠囊殼。Take Danshen Sanqi extract, add 2.5-3.5 times of the weight of the extract of polyethylene glycol-6000, at 85-90 °C, after the chemical is even, add the finely sifted borneol according to the prescription, stir Mix and transfer to a dropping machine to obtain a pellet at 80-85 ° C. Finally, the obtained pellet is wrapped with a 586 nm yellow plant capsule shell.
藥品成分,製法同實施例1,得到素丸後,包裹上572nm綠色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 1. After obtaining the pellet, the 572 nm green plant capsule shell was wrapped.
藥品成分,製法同實施例1,得到素丸後,包裹上對應波長為500nm的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 1. After obtaining the pellet, the plant capsule shell having a wavelength of 500 nm was coated.
藥品成分,製法同實施例1,得到素丸後,包裹上592nm的黃色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 1. After obtaining the pellet, the 592 nm yellow plant capsule shell was wrapped.
藥品成分,製法同實施例1,得到素丸後,包裹上對應波長為577nm的植物膠囊殼。The pharmaceutical ingredient was prepared in the same manner as in Example 1. After obtaining the pill, the plant capsule shell having a corresponding wavelength of 577 nm was wrapped.
藥品成分,製法同實施例1,得到素丸後,包裹上對應波長為592nm的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 1. After obtaining the pellet, the plant capsule shell having a corresponding wavelength of 592 nm was wrapped.
藥品成分,製法同實施例1,得到素丸後,包裹上620nm的橙色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 1. After obtaining the pellet, the 620 nm orange plant capsule shell was wrapped.
藥品成分,製法同實施例1,得到素丸後,包裹上446nm的藍色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 1. After obtaining the pellet, the 466 nm blue plant capsule shell was wrapped.
藥品成分,製法同實施例1,得到素丸後,包裹上580nm的黃色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 1. After the pellet was obtained, a yellow plant capsule shell of 580 nm was coated.
藥品成分,製法同實施例1,得到素丸後,包裹上460nm的藍色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 1. After obtaining the pellet, it was wrapped with a 460 nm blue plant capsule shell.
藥品成分,製法同實施例1,得到素丸後,包裹上550nm的綠色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 1. After obtaining the pellet, the green plant capsule shell of 550 nm was wrapped.
丹參41.06g 三七8.03g 冰片0.46gSalvia 41.06g Sanqi 8.03g borneol 0.46g
輔料聚乙二醇-6000 18gExcipients Polyethylene Glycol-6000 18g
製成1000粒滴丸Made of 1000 pills
取經粗粉碎的丹參、三七藥材至提取罐中,加入該丹參和三七藥材的5倍量pH為9的NaOH水溶液,煎煮2小時進行過濾,濾渣進行第二次提取,加入該丹參和三七藥材的4倍量的上述鹼溶液,煎煮1小時進行過濾,濾渣棄去,合併濾液。濾液減壓濃縮至相對密度為1.25,緩慢加入95%(v/v)的乙醇,使藥液含醇濃度在69-71%(v/v),靜置12小時。取醇沉積後藥液的上清液進行過濾,濾液回收乙醇,收膏至糖度為90 brix的提取物。The coarsely pulverized Danshen and Sanqi medicinal materials were taken into the extraction tank, and 5 times of the NaOH aqueous solution of the Salvia miltiorrhiza and the Panax notoginseng was added, and the mixture was decocted for 2 hours for filtration, and the filter residue was extracted for the second time, and the Salvia miltiorrhiza was added. Four times the amount of the above alkaline solution of the medicinal material of Panax notoginseng was boiled for 1 hour, filtered, and the filter residue was discarded, and the filtrate was combined. The filtrate was concentrated under reduced pressure to a relative density of 1.25, and 95% (v/v) of ethanol was slowly added to make the drug solution having an alcohol concentration of 69-71% (v/v) and allowed to stand for 12 hours. The supernatant of the drug solution after alcohol deposition was filtered, and the filtrate was recovered to ethanol, and the extract was collected to an extract having a sugar content of 90 brix.
取丹參三七浸膏,加入浸膏重量的2.5-3.5倍的聚乙二醇-6000,於85-90℃化料,化料均勻後,按處方量加入研細過篩後的冰片,攪拌混勻,轉移至滴丸機於80-85℃滴製得到小滴丸素丸。Take Danshen Sanqi extract, add 2.5-3.5 times of the weight of the extract of polyethylene glycol-6000, at 85-90 °C, after the chemical is even, add the finely sifted borneol according to the prescription, stir Mix and transfer to a dropping machine to drip at 80-85 ° C to obtain a small drop pill.
按照包衣增重6wt%的比例用水溶解胃溶型包衣材料,充分攪拌均勻後,將素丸轉移到包衣設備內,在平均進風溫度85℃、平均片床溫度35-38℃、霧化壓力2bar、平均轉速15-23rpm、平均物料流速3-4g/min的條件下進行包衣,得到包衣丸。Dissolving the stomach-soluble coating material in water at a ratio of 6 wt% of the weight gain of the coating, fully stirring, and transferring the pill into the coating device at an average inlet air temperature of 85 ° C, an average bed temperature of 35-38 ° C, The coating was carried out under the conditions of an atomization pressure of 2 bar, an average rotation speed of 15 to 23 rpm, and an average material flow rate of 3-4 g/min to obtain a coated pellet.
最後,將得到的包衣丸包裹上586nm黃色的植物膠囊殼即得。Finally, the obtained coated pellets were wrapped on a 586 nm yellow plant capsule shell.
藥品成分,製法同實施例12,包裹上572nm的綠色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12, and was coated with a 572 nm green plant capsule shell.
藥品成分,製法同實施例12,包裹上對應波長為500nm的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12, and the plant capsule shell having a wavelength of 500 nm was coated.
藥品成分,製法同實施例12,包裹上592nm的黃色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12, and a 592 nm yellow plant capsule shell was wrapped.
藥品成分,製法同實施例12,包裹上對應波長為577nm的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12, and the plant capsule shell having a corresponding wavelength of 577 nm was wrapped.
藥品成分,製法同實施例12,包裹上對應波長為592nm的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12, and the plant capsule shell having a corresponding wavelength of 592 nm was wrapped.
藥品成分,製法同實施例12,包裹上620nm的橙色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12, and wrapped in a 620 nm orange plant capsule shell.
藥品成分,製法同實施例12,包裹上446nm的藍色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12 and wrapped in a 446 nm blue plant capsule shell.
藥品成分,製法同實施例12,包裹上580nm的黃色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12, and was coated with a yellow plant capsule shell of 580 nm.
藥品成分,製法同實施例12,包裹上460nm的藍色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12 and wrapped in a 460 nm blue plant capsule shell.
藥品成分,製法同實施例12,包裹上550nm的綠色的植物膠囊殼。The pharmaceutical composition was prepared in the same manner as in Example 12, and wrapped on a 550 nm green plant capsule shell.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW100106101A TWI571257B (en) | 2011-02-23 | 2011-02-23 | Capsule preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW100106101A TWI571257B (en) | 2011-02-23 | 2011-02-23 | Capsule preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201235036A TW201235036A (en) | 2012-09-01 |
TWI571257B true TWI571257B (en) | 2017-02-21 |
Family
ID=47222503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW100106101A TWI571257B (en) | 2011-02-23 | 2011-02-23 | Capsule preparation |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI571257B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3784684A (en) * | 1971-08-24 | 1974-01-08 | Bayer Ag | Coronary dilator in a pharmaceutical dosage unit form |
CN1348815A (en) * | 2001-11-09 | 2002-05-15 | 天津天士力制药股份有限公司 | Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
CN1723998A (en) * | 2005-07-16 | 2006-01-25 | 叶耀良 | Compound red-rooted salvia prepn., and its prepn. method |
-
2011
- 2011-02-23 TW TW100106101A patent/TWI571257B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3784684A (en) * | 1971-08-24 | 1974-01-08 | Bayer Ag | Coronary dilator in a pharmaceutical dosage unit form |
CN1348815A (en) * | 2001-11-09 | 2002-05-15 | 天津天士力制药股份有限公司 | Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
CN1723998A (en) * | 2005-07-16 | 2006-01-25 | 叶耀良 | Compound red-rooted salvia prepn., and its prepn. method |
Also Published As
Publication number | Publication date |
---|---|
TW201235036A (en) | 2012-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011103789A1 (en) | Capsule of complex danshen drop pill | |
KR102123972B1 (en) | Pharmaceutical composition for treating headache, and preparation method thereof | |
WO2005079823A1 (en) | Plant-based medicament for the treatment of hepatitis c | |
CN103977179B (en) | Medicine substance with anti-dementia effect and preparation method and application thereof | |
CN101732463B (en) | Quality detection method for Jinhuaxiaocuo pills | |
Aly et al. | Characterization of 6-gingerol for in vivo and in vitro ginger (Zingiber officinale) using high performance liquid chromatography | |
CN104614475B (en) | A kind of detection method of content for clear particle of quenching one's thirst | |
CN102861255A (en) | Preparation method and quality control method for medicine and preparation thereof for treating influenza | |
TWI571257B (en) | Capsule preparation | |
CN103977180B (en) | Traditional Chinese medicine substance formula with anti-depression effect and preparation method and application thereof | |
CN101209341B (en) | Chinese medicinal preparation, preparation and detection method thereof | |
CN102038869B (en) | Quality control method of traditional Chinese medical preparation | |
CN103977336A (en) | Pharmaceutical composition with myocardial ischemia resisting effect and preparation method and application thereof | |
CN107802678A (en) | A kind of scattered preparation method of larynx health | |
CN103349724A (en) | Anemarrhenae rhizoma total flavone extract and method for concurrently preparing anemarrhenae rhizoma total flavone extract and anemarrhenae rhizoma total saponin extract | |
CN107014945B (en) | A kind of detection method of Chinese medicine preparation that treating acute infectious hepatitis | |
CN102641342A (en) | Traditional Chinese medicine extract for treating nephropathy and preparation method | |
CN102309543A (en) | Compound salvia miltiorrhiza concentrated preparation and preparation and detection method thereof | |
CN100446804C (en) | Heat clearing Chinese proprietary capsule(tablet) of 'Ganlu Xiaodu' for treating cold and its preparation process | |
CN101002809A (en) | Medicine preparation containing extractive of Zi-Jin-Sha, preparing method and use thereof | |
CN100434092C (en) | Prescription containing sweet clover component and its formulation | |
CN118021750B (en) | Preparation method of throat clearing capsule | |
CN102125590B (en) | Ginsenoside Rg1-containing pseudo-ginseng active ingredient as well as preparation method and application thereof | |
CN104224926B (en) | Traditional Chinese medicine extract for removing cigarette and wine toxins as well as preparation method and application thereof | |
CN111407790A (en) | Inclusion method of dalbergia wood volatile oil and preparation method of Shuxinning tablet |